Physician

Stephen Joel Saxe, MD, FACS

According to 2025 Medicare claims, Stephen Saxe, MD, FACS (NPI: 1699750844) practices ophthalmology in the Indianapolis-Carmel-Greenwood, IN market, with the plurality of this provider's patient population coming from Marion, IN. This provider's primary affiliated billing organization is RAJ K. MATURI MD PC (NPI: 1467699090; TIN: 35-2076654) and primary practice location at 46032-9998.

Saxe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 659 traditional Medicare patients, billed 45,980 HCPCS/CPT codes, and received $2,718,453 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 393 prescription claims across 139 beneficiaries totaling $18,949 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 5 records totaling $125. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,855,538 and ending at $2,718,453. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $69,827 to $18,949. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.7M2015 Medicare payment: $1,855,538 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,550,509 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,287,879 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $686,165 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,008,352 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,274,207 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,558,286 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,706,228 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,944,245 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,718,453 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201562210,716$1,855,538
201668312,335$2,550,509
201783910,805$2,287,879
20185804,643$686,165
20196847,215$1,008,352
20207247,684$1,274,207
20217498,566$1,558,286
20227119,409$1,706,228
202365019,859$1,944,245
202465945,980$2,718,453

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$47K$94K2015 Drug cost: $69,827 (USD; Tot_Drug_Cst)2016 Drug cost: $93,677 (USD; Tot_Drug_Cst)2017 Drug cost: $87,750 (USD; Tot_Drug_Cst)2018 Drug cost: $20,830 (USD; Tot_Drug_Cst)2019 Drug cost: $27,037 (USD; Tot_Drug_Cst)2020 Drug cost: $38,457 (USD; Tot_Drug_Cst)2021 Drug cost: $20,483 (USD; Tot_Drug_Cst)2022 Drug cost: $40,571 (USD; Tot_Drug_Cst)2023 Drug cost: $24,081 (USD; Tot_Drug_Cst)2024 Drug cost: $18,949 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015136678$69,827
2016163796$93,677
2017135615$87,750
201878225$20,830
201978236$27,037
202098307$38,457
202189247$20,483
202289234$40,571
2023103272$24,081
2024139393$18,949

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1591,324$646
67028Injection of drug into eye4651,541$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more376529$63
92134Imaging of retina5971,743$29
J2777Injection, faricimab-svoa, 0.1 mg15434,984$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol13906$5,466
Prednisolone AcetatePrednisolone Acetate281,282$1,714
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol16980$1,322
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine13363$1,123
LatanoprostLatanoprost543,910$695

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$125Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Stephen Joel Saxe, MD, FACS?

Tedicare shows public-source Medicare data for Stephen Joel Saxe, MD, FACS (NPI 1699750844), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen Joel Saxe, MD, FACS have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephen Joel Saxe, MD, FACS?

Stephen Joel Saxe, MD, FACS is linked to RAJ K. MATURI MD PC (billing NPI 1467699090) in the available physician profile data.

Does Stephen Joel Saxe, MD, FACS have Open Payments data?

Stephen Joel Saxe, MD, FACS has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.